Europe Deep Brain Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Europe · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$307.0 MnPlaceholder estimate
Estimate 2025$331.2 Mn19.9% of the global market
Projected 2034$656.6 Mn 98.2%Adds $325.4 Mn over 9 forecast years
CAGR 2025–20347.9%Faster than 52% of 173 Medical Devices markets here
Key players5
Europe is 19.91% of the global market.
Among regions, the largest is North America at $928.7 Mn.
35 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Europe Deep Brain Stimulation Market Analysis Executive Summary
Deep brain stimulation places thin wires in the brain connected to a pacemaker-like device, to treat Parkinson's, tremor and other conditions.
Key segments of the deep Brain Stimulation market include product (Single-Channel, Dual-Channel and Rechargeable) and indication (Parkinson's, Essential Tremor and Dystonia).
Europe Deep Brain Stimulation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Europe Deep Brain Stimulation Market Dynamics
Market Growth Drivers
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
Opportunity
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the deep Brain Stimulation market strong room to grow.
Market Restraints
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the deep Brain Stimulation market.
Competitive Landscape for Deep Brain Stimulation Market in Europe
The deep Brain Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Deep Brain Stimulation Market in Europe
Deep Brain Stimulation in Europe: rules, payment and research
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8] ClinicalTrials.gov lists 35 studies on Deep Brain Stimulation that are recruiting, active or about to start in Europe.[9]
[9]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how deep Brain Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By Indication
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Medtronic
7.2 Boston Scientific
7.3 Abbott Laboratories
7.4 Newronika
7.5 SceneRay
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The deep Brain Stimulation market can be segmented based on various criteria, including product, indication and end user. Here's a breakdown of the market segmentation
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Deep Brain Stimulation market in Europe?
Placeholder estimate: about $331.2 Mn in 2025, rising to about $656.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Deep Brain Stimulation market in Europe growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Deep Brain Stimulation market report cover?
The report splits the market by product (Single-Channel, Dual-Channel, Rechargeable, Adaptive Systems), indication (Parkinson's, Essential Tremor, Dystonia, Epilepsy and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Deep Brain Stimulation market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika and SceneRay.
What is driving the Deep Brain Stimulation market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
Who regulates Deep Brain Stimulation in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Deep Brain Stimulation are running in Europe?
35 studies are recruiting, active or about to start in Europe, counted across the 6 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Deep Brain Stimulation?
PubMed lists 7,259 papers on Deep Brain Stimulation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
US
China
Canada
Japan
Germany
France
Brazil
Italy
UK
Ecuador
Spain
India
Saudi Arabia
Mexico
Australia
New Zealand
Russia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Thailand
Singapore
Kenya